drugset / Trial / NCT05155995
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetic characteristics and safety between HCP2001 and co-administration of each component in fasting and fed conditions respectively in healthy volunteers.
Timeline
- Start
- 2021-09-28
- Primary completion
- 2022-11-27
- Completion
- 2022-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCP2001 | Unknown | — | — |
| Subject | RLD2007 | Unknown | — | — |
| Subject | RLD2008 | Unknown | — | — |
| Subject | RLD2102 | Unknown | — | — |
Indications
No indication recorded.